'Abortion Test' Sparks Concern; AI in Brain Surgery; 'Is There a Doctor on Board?' Health news and commentary from around the Web gathered by staff Oct 12, 2023
Rare Lung Bleeds Cluster in DOAC Users, Implications Unclear Pattern found in diffuse alveolar hemorrhage reports in FAERS Oct 11, 2023
Primary Care Intervention Improved Follow-Up of Abnormal Cancer Screening Results Follow-up testing within 120 days was improved with EHR reminders, patient outreach, navigation Oct 10, 2023
HER3-Targeted Drug Active in Advanced/Metastatic Breast Cancer Durable responses across all three major subtypes of breast cancer Oct 10, 2023
How a Multi-Cancer Screening Test Would Play Out in the Clinic True positives identified with Grail's assay typically confirmed in under 2 months Oct 10, 2023
Chemo Shortage: 'Paycheck to Paycheck'; Cancer Blood Test Shines; Struggling to Live News, features, and commentary about cancer-related issues Oct 06, 2023
Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBC Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panel But agency doesn't plan to immediately push for KRAS inhibitor's withdrawal Oct 05, 2023
Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? Detectable circulating tumor DNA before radiotherapy linked with worse survival Oct 05, 2023
FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in Remission Large improvement in event-free survival, but questions linger about sources of data Oct 04, 2023
Use of Recent Diagnostic CT Scans for Palliative RT Planning Reduced Treatment Time Time to treatment completion slashed by over 4 hours compared with CT simulation planning Oct 04, 2023
Drugmaker Plans to Pull Lung Cancer Therapy From the Market Randomized trial of mobocertinib (Exkivity) failed to confirm benefit in rare tumor type Oct 04, 2023
FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC Reviewers see potentially tiny PFS benefit with sotorasib, raise concerns over "systemic bias" Oct 04, 2023
Hypofractionated RT for Breast Cancer Post-Mastectomy as Effective as Standard RT Randomized trial a "game changer" for patients who have implant-based reconstruction, expert says Oct 04, 2023
In BRCA Breast Cancer, Prophylactic Salpingo-Oophorectomy Tied to Better Survival PSO should be performed early, particularly for those with the BRCA1 variant, researchers say Oct 04, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
FDA Advisors to Consider DFMO Maintenance for High-Risk Neuroblastoma in Kids Lack of options for relapsed disease versus uncertainty about supporting data Oct 03, 2023
FDA Greenlights Test for Cancer-Predisposing Genetic Mutations First-of-its-kind DNA test achieved 99% accuracy for variants in dozens of genes Oct 03, 2023
Sexual Activity Lowers Risk of Side Effects After Cervical Cancer Treatment Intercourse and/or vaginal dilation reduces risk of vaginal stenosis Oct 03, 2023
Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Children Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
ABIM CEO Retirement Comes Amid Wave of Criticism Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancer Combination may "provide meaningful antitumor activity," researchers say Sep 28, 2023
Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening News, features, and commentary about cancer-related issues Sep 28, 2023
Report: Persistence of Gender Inequalities in Cancer Care, and a Call to Action Premature deaths, lack of access to services, leadership inequalities highlighted Sep 27, 2023
Cancer Risk in NAFLD Higher With Early Disease Onset 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
Study Confirms Better Survival for HPV-Positive Cervical Cancer Source, interpretation of negative tests remain open to speculation Sep 26, 2023
When Screening Guidelines Collide, Who Wins? A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelines Survivors classified as exercisers have 25% reduced risk of all-cause mortality, study shows Sep 23, 2023
The White House Cancer Moonshot Is a Dud We're failing to take simple steps to reduce one of the biggest causes of cancer Sep 22, 2023
TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology News, features, and commentary about cancer-related issues Sep 21, 2023
Ultrasound May Help Early Breast Cancer Patients Avoid SLNB No axillary surgery matches SLNB for patients with a negative ultrasound of axillary lymph nodes Sep 21, 2023
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial Histological complete response rates no better and survival appears worse Sep 19, 2023
Large Study Eases Fears Over Zantac-Cancer Link In multinational cohort, cancer incidence with pulled drug no different than other H2RAs Sep 19, 2023
Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC? Strategy tied to better outcomes but fails to meet primary goal of phase II trial Sep 18, 2023
